Quintiles says payers driving demand for market access offering
US CRO Quintiles says healthcare payer influence is driving pharmaceutical industry demand for market access services.
US CRO Quintiles says healthcare payer influence is driving pharmaceutical industry demand for market access services.
BASF and Colorcon are developing a tablet film coating technology with improved taste masking and barrier properties.
WuXi PharmaTech has expanded into Phase I-IV clinical trial services through the acquisition of two China-based CROs.
In the next 25 years pharma will shift from batch to continuous manufacturing and make current production methods “obsolete”, an FDA director said.
in-PharmaTechnologist presents its round-up of the latest appointments within the pharmaceutical industry, including news from Novocure, YM BioSciences, and SGVI.